TherapeuticsMD, Inc. (TXMD) [Rocket]

Date Filed	Type	Description
09/21/2020	GN	Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®
09/21/2020	GN	Knight et TherapeuticsMD annoncent l'approbation par Santé Canada de BIJUVA®
03/05/2019	GN	Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson — Fundamental Analysis, Key Performance Indications
10/24/2018	GN	Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD — Fundamental Analysis, Key Performance Indications
05/16/2018	BW	TherapeuticsMD Announces Investor and Analyst Day on June 4
05/03/2018	BW	TherapeuticsMD Announces First Quarter 2018 Financial Results
05/01/2018	BW	TherapeuticsMD to Host First Quarter Financial Results Conference Call and Webcast on May 3
03/06/2018	BW	TherapeuticsMD to Present at Two Upcoming Investor Conferences
02/20/2018	BW	TherapeuticsMD Announces Fourth Quarter and Full Year 2017 Financial Results
02/15/2018	GN	Research Report Identifies Louisiana-Pacific, Vmware, ZAGG, FS Investment, TherapeuticsMD, and Kennedy-Wilson with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
02/06/2018	BW	TherapeuticsMD to Host Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast on February 20
12/01/2017	GN	Recent Analysis Shows FS Investment, TherapeuticsMD, Kennedy-Wilson, Louisiana-Pacific, Vmware, and ZAGG Market Influences — Renewed Outlook, Key Drivers of Growth
11/06/2017	BW	TherapeuticsMD Announces Third Quarter 2017 Financial Results
11/03/2017	BW	TherapeuticsMD to Host TX-004HR Regulatory Update and Third Quarter Financial Results Conference Call and Webcast on November 6
08/03/2017	BW	TherapeuticsMD Announces Second Quarter 2017 Financial Results
07/20/2017	BW	TherapeuticsMD to Host Second Quarter Financial Results Conference Call and Webcast on August 3